{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:44:27Z","timestamp":1791531867862,"version":"4.3.4"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,5,18]]},"abstract":"<jats:p>\n            The global dissemination of metallo-\u03b2-lactamase (MBL)-producing carbapenem-resistant\n            <jats:italic>Enterobacterales<\/jats:italic>\n            (CRE) is a serious public health concern. Specifically, NDM (New Delhi MBL) has been a major cause of carbapenem therapy failures in recent years, particularly as effective treatments for serine-\u03b2-lactamase (SBL)-producing\n            <jats:italic>Enterobacterales<\/jats:italic>\n            are now commercially available.\n          <\/jats:p>","DOI":"10.1128\/aac.00203-21","type":"journal-article","created":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T12:54:46Z","timestamp":1617627286000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":42,"title":["Novel Specific Metallo-\u03b2-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive\n            <i>Enterobacterales<\/i>"],"prefix":"10.1128","volume":"65","author":[{"given":"Magdalena","family":"Zalacain","sequence":"first","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Lozano","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Llanos","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sprynski","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Valmont","sequence":"additional","affiliation":[{"name":"IHMA Europe S\u00e0rl, Monthey, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyntia","family":"De Piano","sequence":"additional","affiliation":[{"name":"IHMA Europe S\u00e0rl, Monthey, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Davies","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Leiris","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Sable","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Ledoux","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Morrissey","sequence":"additional","affiliation":[{"name":"IHMA Europe S\u00e0rl, Monthey, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lemonnier","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2002-1805","authenticated-orcid":true,"given":"Martin","family":"Everett","sequence":"additional","affiliation":[{"name":"Antabio SAS, Lab\u00e8ge, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2019.04.002"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2018.04.005"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2018.00016"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00107.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy347"},{"key":"e_1_3_1_7_2","unstructured":"O\u2019Neill J. 2016. Review on antimicrobial resistance: tackling drug-resistant infections globally. https:\/\/amr-review.org\/home.html"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw282"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2017.11.002"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00698-18"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1660772"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01279"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00397-20"},{"key":"e_1_3_1_14_2","unstructured":"Marcoccia FDLF Devente S Cerboni G Davies D Sprynski N Everett M Lemmonnier M Docquier JD. 2019. Interaction of the metallo-\u03b2-lactamase inhibitor ANT2681 with NDM-type enzymes shows a pH-dependent potency and in vitro antibacterial activity poster FRIDAY-AAR-LB-12. ASM Microbe 20-24 June 2019 San Francisco CA."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.0c00207"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01076-20"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1756775"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003257225"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2010.06.012"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku568"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa353"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01659-20"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-3"},{"key":"e_1_3_1_24_2","unstructured":"Centers for Disease Control. 2019. Antibiotic resistance threats in the United States. Centers for Disease Control Atlanta GA."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1151-1161.2001"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-018-0617-x"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00127"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2011.07.026"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00774-09"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/249856"},{"key":"e_1_3_1_31_2","unstructured":"NIH. 2021. Safety and efficacy study of cefepime\/VNRX-5133 in patients with complicated urinary tract infections. National Institutes of Health Bethesda MD. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03840148."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw231"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00414-18"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02243-16"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01008-17"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa586"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky522"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx050"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01406-20"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00389-17"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0699-6"},{"key":"e_1_3_1_42_2","volume-title":"Performance standards for antimicrobial susceptibility testing; 30th informational supplement; document M100-S30.","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. 2020. Performance standards for antimicrobial susceptibility testing; 30th informational supplement; document M100-S30. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2015.03.025"},{"key":"e_1_3_1_44_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards, eleventh edition; document M07-A11.","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards, eleventh edition; document M07-A11. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_1_45_2","volume-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0. 2020.","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2020","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2020. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0. 2020. EUCAST, V\u00e4xj\u00f6, Sweden."},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajodo.2016.10.001"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00203-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00203-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:25:37Z","timestamp":1645485937000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00203-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,5,18]]}},"alternative-id":["10.1128\/AAC.00203-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.00203-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"2021-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00203-21"}}